文献速递乳腺乳腺X线

在瑞典环境中数字乳腺断层摄影用于乳腺癌筛查的成本效果分析

Cost effectiveness of digital breast tomosynthesis for breast cancer screening in a Swedish setting.
PubMed 文献 · Eur J Radiol · 2025-04-12

基于马尔默乳腺断层摄影筛查试验(MBTST)数据,采用卫生经济学模型比较40-74岁女性中数字乳腺断层摄影(DBT)与数字乳腺摄影(DM)筛查的成本效果。DBT筛查每10万名受邀女性估计多检出56例浸润性癌、减少18例间期癌;DBT具有成本效果所需的乳腺癌死亡率相对下降幅度在最低与最高评估成本和支付意愿情境下为2.3%至14.2%。结论认为DBT筛查的成本效果取决于预期乳腺癌死亡率相对下降和筛查支付意愿,且结果受DBT筛查检查未来成本驱动。

要点

  • DBT筛查每10万名受邀女性较DM多检出56例浸润性癌、减少18例间期癌。
  • DBT具有成本效果所需的乳腺癌死亡率相对下降幅度随成本和支付意愿情境变化,范围2.3%至14.2%。
  • 在DBT检查成本61欧元、支付意愿阈值50,000欧元/QALY时,所需死亡率相对下降为3.6%。

核心结论

  • 模型分析显示DBT筛查的成本效果取决于预期乳腺癌死亡率相对下降和筛查支付意愿,且结果受DBT筛查检查未来成本驱动。

研究设计与样本

  • 卫生经济学模型分析,比较40-74岁女性中DBT筛查方案与DM筛查方案;人口学、乳腺癌发病率和死亡率模型输入值来自区域登记数据库;DBT对检出率和间期乳腺癌的影响基于MBTST。

诊断标准与关键数值

  • 与DM相比,DBT筛查每10万名受邀女性估计多检出56例浸润性癌、减少18例间期癌。
  • DBT具有成本效果所需的乳腺癌死亡率相对下降幅度在最低与最高评估成本和支付意愿情境下为2.3%至14.2%。
  • 在DBT检查成本61欧元、支付意愿阈值50,000欧元/QALY时,所需乳腺癌死亡率相对下降为3.6%。

局限性

  • 关键信息尚不可获得,研究使用情景分析探索达到10,000至50,000欧元/QALY支付意愿阈值所需的乳腺癌死亡率相对下降。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: In the Malmö Breast Tomosynthesis Screening Trial (MBTST), digital breast tomosynthesis (DBT) increased the detection rate of breast cancer compared to currently used digital mammography (DM). This study evaluated the cost effectiveness of DBT versus DM in Sweden using data from MBTST.

MATERIALS AND METHOD: A health economic model was used to compare a breast cancer screening programme using DBT to breast cancer screening using DM in women aged 40-74. Model input values on demographics, breast cancer incidence and mortality were derived from regional registries. The effect of DBT on detection rates and interval breast cancer was based on MBTST. Key information is not yet available and scenario analyses were used to explore the reduction in relative breast cancer mortality required to meet willingness-to-pay thresholds between €10,000 and €50,000/quality-adjusted life year (QALY), assuming three levels of DBT examination cost.

RESULTS: Compared with DM, DBT-screening was estimated to detect 56 more invasive cancers and 18 fewer interval cancers per 100,000 invited women. The relative reduction in breast cancer mortality for DBT to be cost effective varied between 2.3 and 14.2% for the lowest versus highest evaluated cost and willingness-to-pay scenarios. The required reduction at a DBT cost and willingness-to-pay threshold of €61 and €50,000/QALY respectively was 3.6%.

CONCLUSION: This model analysis shows that the cost effectiveness of DBT-screening is dependent on the expected relative reduction in breast cancer mortality and the willingness-to-pay for screening. Furthermore, the results are driven by the future costs for DBT-screening examinations.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Fridhammar A, Johnson K, Rosso A, et al. Cost effectiveness of digital breast tomosynthesis for breast cancer screening in a Swedish setting. Eur J Radiol. 2025. PMID: 40273760. doi:10.1016/j.ejrad.2025.112088

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。